Valvular & structural heart diseaseCohort study

Atrial Functional Tricuspid Regurgitation in Patients Undergoing Transcatheter Aortic Valve Replacement

JACC Cardiovasc IntervPublished

  • Retrospective cohort study

Authors' conclusion

In TAVR patients, afTR is an independent predictor for TR persistence. Moreover, TR persistence is associated with increased 3-year all-cause mortality.

Study context

Population
Patients undergoing transcatheter aortic valve replacement (TAVR) for severe AS (January 2013 to December 2020) with concomitant at least moderate tricuspid regurgitation (TR) at baselineof 3,474 TAVR patients
Participants
363 patients
Exposure
Atrial functional tricuspid regurgitation (afTR) vs non-afTR
  • afTRn = 178
  • non-afTRn = 185reference
Outcome
TR development after TAVR

Main finding

TR improvement after TAVR

Adjusted odds ratio

2.80

95% CI 1.66–4.76

P < 0.001

By group

afTR vs non-afTR
adjusted OR 2.80 (95% CI 1.66–4.76); P < 0.001

As reported in the abstract

Observational data: associations, not effects.

Further findings

Aggravation of TR after TAVR

P = 0.013

All-cause mortality, TR persistence vs TR improvement · 3 years

Significantly higher with TR persistence than with TR improvement
P < 0.001

Original publication

Atrial Functional Tricuspid Regurgitation in Patients Undergoing Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. Published 8 January 2024. doi:10.1016/j.jcin.2023.10.069

Summarised from the published abstract; every number is checked against it